本页面由Tiger Trade Technology Pte. Ltd.提供服务

Esperion Therapeutics Inc.

2.63
-0.1100-4.01%
盘后2.630.00000.00%16:57 EDT
成交量:635.07万
成交额:1,669.80万
市值:6.75亿
市盈率:-24.10
高:2.86
开:2.74
低:2.54
收:2.74
52周最高:4.18
52周最低:0.6925
股本:2.57亿
流通股本:2.37亿
量比:1.64
换手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-0.1091
每股收益(LYR):-0.1091
净资产收益率:97.76%
总资产收益率:9.30%
市净率:-2.24
市盈率(LYR):-24.10

数据加载中...

2022/05/26

重要事件披露

8-K - Current report
2022/05/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/03

重要事件披露

8-K - Current report
2022/04/28

重要事件披露

8-K - Current report
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/15

重要事件披露

8-K - Current report
2022/03/01

重要事件披露

8-K - Current report
2022/02/22

重要事件披露

8-K - Current report
2022/02/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

重要事件披露

8-K - Current report
2022/01/04

重要事件披露

8-K - Current report
2021/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals